Mitral regurgitation severity dynamic during acute decompensated heart failure treatment
Open Access
- 22 December 2021
- journal article
- research article
- Published by Springer Nature in The International Journal of Cardiovascular Imaging
- Vol. 38 (5) , 1113-1119
Abstract
Acute decompensated heart failure (ADHF) treatment leads to significant hemodynamic changes. The aim of our study was to quantitatively analyze the dynamics of mitral regurgitation (MR) severity (evaluated by transthoracic echocardiography) which occur during the treatment of ADHF and to correlate these changes with the clinical condition of patients as well as heart failure biochemical markers. The study included 27 consecutive adult patients (40.7% females, mean age 71.19 ± 11.2 years) who required hospitalization due to signs of acute HF. Echocardiographic assessment was performed upon admission and discharge together with clinical and laboratory evaluation. Significant reduction in dyspnea intensity [0–100 scale] (81.48 ± 9.07 vs. 45.00 ± 11.04 pts, p < 0.001), body weight (84.98 ± 18.52 vs. 79.77 ± 17.49 kg, p < 0.001), and NT-proBNP level (7520.56 ± 5288.62 vs. 4949.88 ± 3687.86 pg/ml, p = 0.001) was found. The severity of MR parameters decreased significantly (MR volume 44.92 ± 22.83 vs. 30.88 ± 18.77 ml, p < 0.001; EROA 0.37 ± 0.17 vs. 0.25 ± 0.16 cm2, p < 0.001; VC 6.21 ± 1.48 vs. 5.26 ± 1.61 mm, p < 0.001). Left atrial area (35.86 ± 9.11 vs. 32.47 ± 9.37, p < 0.001) and mitral annular diameter (42.33 ± 6.63 vs. 39.72 ± 5.05. p < 0.001) also underwent statistically significant reductions. An increase in LVEF was observed (34.73 ± 13.88 vs. 40.24 ± 13.19%, p < 0.001). In 40.7% of patients, a change in MR severity class (transition from a higher class to a lower one) was observed: 6/8 (75%) patients transitioned from severe to moderate and 6/18 (33.3%) patients transitioned from moderate to mild class. Treatment of ADHF leads to a significant reduction in MR severity, together with significant reductions in left atrial and mitral annular dimensions. Quantitative measurement of MR dynamics offer valuable assistance for ADHF management.Keywords
All Related Versions
Funding Information
- Uniwersytet Jagielloński Collegium Medicum (K/2DS/007820)
This publication has 16 references indexed in Scilit:
- 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failureEuropean Heart Journal, 2016
- Meta-Analysis of the Usefulness of Mitraclip in Patients With Functional Mitral RegurgitationThe American Journal of Cardiology, 2015
- Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular ImagingJournal of the American Society of Echocardiography, 2015
- Echocardiographic Changes During Treatment of Acute Decompensated Heart Failure: Insights From the ESCAPE TrialJournal of Cardiac Failure, 2012
- Intravenous Nitroglycerin in the Treatment of Decompensated Heart Failure: Potential Benefits and LimitationsJournal of Cardiovascular Pharmacology and Therapeutics, 2004
- Ischemic Mitral RegurgitationCirculation, 2001
- The mechanism of decrease in dynamic mitral regurgitation during heart failure treatment: importance of reduction in the regurgitant orifice sizeJACC, 1998
- Impact of left ventricular cavity size on survival in advanced heart failureThe American Journal of Cardiology, 1993
- Hemodynamic response to intravenous enalaprilat in patients with severe congestive heart failure and mitral regurgitationClinical Cardiology, 1993
- Acute reduction of atrial overload during vasodilator and diuretic therapy in advanced congestive heart failureThe American Journal of Cardiology, 1990